glp 1 2024 GLP-1 Coverage in Employer Plans Could Nearly Double in GLP-1 Receptor Agonist Market Size,

Future studies should aim to elucidate the mechanisms underlying these contradictory observations and identify the specific conditions under which GLP-1RAs might exert detrimental effects on the CNS

Some of the well-known ones include: Ozempic (semaglutide): Approved in 2017 for type 2 diabetes, also commonly used off-label for weight management

They have proved highly effective in driving LDL cholesterol numbers down in several groups of patients at high risk of having first or repeat heart attacks or strokes

As summarized in Fig

Urinary tract infections (UTIs) are among the most common causes of haematuria, particularly in women

However, further research is necessary to confirm any link